Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00619463 · ClinicalTrials.gov registry record · NA

Effects of Aerobic Exercise on Cognition, Mood and Fatigue Following TBI

A NA study of Traumatic Brain Injury, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
154
Enrollment target
1
Study location

NCT00619463 is a NA study of Traumatic Brain Injury that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 154 participants, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00619463, a NA study of Traumatic Brain Injury, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
154 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine the efficacy of aerobic exercise for improving cognition, mood, and fatigue after Traumatic Brain Injury (TBI) as well as examine the role of Brain Derived Neurotropic Factor (BDNF) and peripheral Vascular Endothelial Growth Factor (VEGF) as mediators of response to exercise.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2007-08
Est. Completion 2012-10
Phase NA

What the Registry Record Tells You About NCT00619463

The ClinicalTrials.gov registry entry for NCT00619463 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (44% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.

NCT00619463 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00619463 about?

NCT00619463 is a clinical study titled "Effects of Aerobic Exercise on Cognition, Mood and Fatigue Following TBI". The purpose of the study is to determine the efficacy of aerobic exercise for improving cognition, mood, and fatigue after Traumatic Brain Injury (TBI) as well as examine the role of Brain Derived Neurotropic Factor (BDNF) and peripheral Vascular Endothelial Growth Factor (VEGF) as mediators of resp...

What is the current status of trial NCT00619463?

This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2007-08. Estimated completion is 2012-10.

What conditions does trial NCT00619463 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT00619463?

The interventions under investigation include: Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT00619463?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00619463 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.